| http://www.w3.org/ns/prov#value | - Neurocrine Biosciences: Solid Financials, Strong Pipeline 2 comments | by: Harm Diaconescu June 22, 2011 | about: ABT, GSK, NBIX Font Size: PrintEmail Recommend 1 Share this pageShare Neurocrine Biosciences Inc. (NBIX) is a biopharmaceutical company engaged in research and development of medications addressing metabolic system-related diseases and neurological disorders such as anxiety, depression
|
